This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of California. Active years: 2014-2016.
Location History:
- Princeton, NJ (US) (2015)
- San Francisco, CA (US) (2014 - 2016)
Company Filing History:
Years Active: 2014-2016
Title: Alexei Korennykh: Innovator in Modulating Cellular Activity
Introduction
Alexei Korennykh is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cellular biology, particularly in the modulation of specific cellular activities. With a total of 3 patents to his name, Korennykh's work has implications for treating various diseases.
Latest Patents
Korennykh's latest patents include innovative methods and compositions for modulating Ire1, Src, and Abl activity. These patents disclose compositions for modulating these proteins, methods for identifying modulating activity in test compounds, and approaches for treating diseases caused by the activity or inactivity of Ire1, Src, or Abl. Additionally, he has developed methods for inhibiting Ire1 activity, showcasing his focus on cellular modulation.
Career Highlights
Throughout his career, Korennykh has worked with esteemed institutions such as the University of California and Fundación Ciencia Para La Vida. His research has contributed to a deeper understanding of cellular mechanisms and potential therapeutic interventions.
Collaborations
Some of his notable coworkers include Peter Walter and Arvin C. Dar. Their collaborative efforts have further advanced the research in the field of cellular biology.
Conclusion
Alexei Korennykh's innovative work in modulating cellular activity has positioned him as a key figure in the scientific community. His patents and collaborations reflect his commitment to advancing our understanding of cellular processes and developing potential treatments for related diseases.